WMT

114.81

+0.23%↑

145.29

-0.89%↓

70.47

-0.35%↓

148.21

-2.44%↓

PEP

146.84

-0.81%↓

WMT

114.81

+0.23%↑

145.29

-0.89%↓

70.47

-0.35%↓

148.21

-2.44%↓

PEP

146.84

-0.81%↓

WMT

114.81

+0.23%↑

145.29

-0.89%↓

70.47

-0.35%↓

148.21

-2.44%↓

PEP

146.84

-0.81%↓

WMT

114.81

+0.23%↑

145.29

-0.89%↓

70.47

-0.35%↓

148.21

-2.44%↓

PEP

146.84

-0.81%↓

WMT

114.81

+0.23%↑

145.29

-0.89%↓

70.47

-0.35%↓

148.21

-2.44%↓

PEP

146.84

-0.81%↓

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

7.77 2.37

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.42

Max

7.77

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.9M -10M
Verkäufe	-5.3M 31M
Gewinnspanne	-32.116
Angestellte	406

Dividenden
By Dow Jones
Nächstes Ergebnis	2. Jan. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	19M 260M
Vorheriger Eröffnungskurs	5.4
Vorheriger Schlusskurs	7.77

Nachrichtenstimmung

By Acuity

20%

80%

15 / 148 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Dez. 2025, 20:41 UTC

Ergebnisse

Wichtige Markttreiber

America's Car-Mart Rises on Better-Than-Expected 2Q Revenue, $300 Million Term Loan

4. Dez. 2025, 18:14 UTC

Akquisitionen, Fusionen, Übernahmen

Big Yellow Says It Will Terminate Takeover Talks With Blackstone

4. Dez. 2025, 17:43 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Brera Holdings Signs Non-Binding Term Sheet to Acquire RockawayX

4. Dez. 2025, 17:01 UTC

Ergebnisse

TD Bank Pushes Up Dividend After Underlying Earnings, Revenue Beat Expectations -- Update

4. Dez. 2025, 23:45 UTC

Market Talk

Nikkei May Decline Amid Caution Over U.S. Labor Market, Japan Earnings -- Market Talk

4. Dez. 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. Dez. 2025, 21:54 UTC

Market Talk

Global Equities Roundup: Market Talk

4. Dez. 2025, 21:54 UTC

Market Talk

Warehouse's Strategy to Lift Margins Easier Said Then Done -- Market Talk

4. Dez. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

4. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Dez. 2025, 21:48 UTC

Market Talk

Scales Hits Mark With Earnings Guidance -- Market Talk

4. Dez. 2025, 21:37 UTC

Ergebnisse

Aerospace Start-Up Beta Posts Its First Earnings Report. The Stock Rises. -- Barrons.com

4. Dez. 2025, 21:36 UTC

Ergebnisse

These Stocks Moved the Most Today: Meta Platforms, Salesforce, Snowflake, UiPath, Micron, Dollar General, Kroger, and More -- Barrons.com

4. Dez. 2025, 20:15 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. Dez. 2025, 20:15 UTC

Market Talk

Think Tank Calls For Bank of Canada Rate Hold Next Week -- Market Talk

4. Dez. 2025, 20:04 UTC

Market Talk

Natural Gas Futures Extend Gains as U.S. Grows Cold -- Market Talk

4. Dez. 2025, 19:54 UTC

Market Talk

Oil Futures Bolstered by Lasting Ukraine War, U.S. Macro Outlook -- Market Talk

4. Dez. 2025, 19:44 UTC

Akquisitionen, Fusionen, Übernahmen

EQB CEO: PC Financial Deal Adds Scale to Compete With Larger Canadian Banks

4. Dez. 2025, 19:44 UTC

Akquisitionen, Fusionen, Übernahmen

EQB CEO: PC Financial Tie-Up Brings Scale to Reach More Customers

4. Dez. 2025, 19:44 UTC

Akquisitionen, Fusionen, Übernahmen

Equitable Bank Deal for PC Financial Adds Heft to Compete With Canada's Big Banks -- Interview

4. Dez. 2025, 19:33 UTC

Market Talk

Gold Inches Higher as Traders Continue to Mull ADP Jobs Report -- Market Talk

4. Dez. 2025, 19:01 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Raises Concerns About Netflix's Bid for Warner Bros. Discovery -- WSJ

4. Dez. 2025, 19:01 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Wrote to Warner Bros. Discovery Again Wednesday -- WSJ

4. Dez. 2025, 19:01 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Wrote Netflix Deal With Warner Bros. Would Likely 'Never Close,' Monday Letter Says -- WSJ

4. Dez. 2025, 19:01 UTC

Akquisitionen, Fusionen, Übernahmen

Another Round of Bids for Warner Bros. Discovery Due Thursday, Sources Say -- WSJ

4. Dez. 2025, 18:58 UTC

Market Talk

U.S.-Venezuela Military Tension Expected to Lift Oil Prices -- Market Talk

4. Dez. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4. Dez. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4. Dez. 2025, 16:41 UTC

Market Talk

Gold Rises as Traders Await U.S. Inflation Data -- Market Talk

4. Dez. 2025, 16:33 UTC

Market Talk

Ergebnisse

Salesforce Customers Are Gaining Confidence in Agentforce -- Market Talk

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

15 / 148 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.